Year |
Citation |
Score |
2020 |
Wooton-Kee CR, Robertson M, Zhou Y, Dong B, Sun Z, Kim KH, Liu H, Xu Y, Putluri N, Saha P, Coarfa C, Moore DD, Nuotio-Antar AM. Metabolic dysregulation in the Wilson's disease mouse model. Proceedings of the National Academy of Sciences of the United States of America. PMID 31924743 DOI: 10.1073/Pnas.1914267117 |
0.433 |
|
2015 |
Nuotio-Antar AM, Poungvarin N, Li M, Schupp M, Mohammad M, Gerard S, Zou F, Chan L. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. Endocrinology. 156: 4020-32. PMID 26248218 DOI: 10.1210/En.2015-1210 |
0.432 |
|
2015 |
Mehta P, Nuotio-Antar AM, Smith CW. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. Journal of Leukocyte Biology. 97: 121-34. PMID 25395302 DOI: 10.1189/jlb.3A0414-211RR |
0.398 |
|
2014 |
Lin L, Nuotio-Antar AM, Ma X, Liu F, Fiorotto ML, Sun Y. Ghrelin receptor regulates appetite and satiety during aging in mice by regulating meal frequency and portion size but not total food intake. The Journal of Nutrition. 144: 1349-55. PMID 24991043 DOI: 10.3945/jn.114.191171 |
0.354 |
|
2007 |
Nuotio-Antar AM, Hachey DL, Hasty AH. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice. American Journal of Physiology. Endocrinology and Metabolism. 293: E1517-28. PMID 17878220 DOI: 10.1152/Ajpendo.00522.2007 |
0.648 |
|
2006 |
Nuotio-Antar AM, Hasty AH, Kovacs WJ. Quantitation and cellular localization of 11beta-HSD1 expression in murine thymus. The Journal of Steroid Biochemistry and Molecular Biology. 99: 93-9. PMID 16621520 DOI: 10.1016/J.Jsbmb.2006.01.011 |
0.492 |
|
2006 |
Gruen ML, Saraswathi V, Nuotio-Antar AM, Plummer MR, Coenen KR, Hasty AH. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis. 186: 54-64. PMID 16102772 DOI: 10.1016/J.Atherosclerosis.2005.07.007 |
0.384 |
|
Show low-probability matches. |